Paper Details

  1. Home
  2. Paper Details

Stiripentol for the treatment of super-refractory status epilepticus.

Author: KnakeS, KortlandL-M, RosenowF, StrzelczykA

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Stiripentol (STP) was used to treat 5 adults with super-refractory status epilepticus (SRSE). SRSE resolved in 3 patients within 2-4 days after starting STP. STP may be a potential treatment option for SRSE, but prospective trials are needed to confirm its efficacy.
Paper Details　
Original Abstract of the Article :
BACKGROUND: To determine whether stiripentol (STP) might be a treatment option in super-refractory status epilepticus (SRSE). METHODS: Medical records of patients treated due to a status epilepticus in Marburg between January 2013 and June 2014 were reviewed for administration of STP. Primary outco...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/ane.12403

データ提供：米国国立医学図書館（NLM）

Stiripentol for the treatment of super-refractory status epilepticus

This research delves into the challenging realm of [neurology and epilepsy], exploring the potential of stiripentol (STP) as a treatment option for super-refractory status epilepticus (SRSE), a particularly severe and treatment-resistant form of epilepsy. The authors retrospectively analyzed medical records of patients treated with STP for SRSE, finding that in a small cohort, STP effectively ceased SRSE in three out of five patients. This preliminary finding suggests that STP might be a valuable addition to the therapeutic arsenal for managing SRSE.

Stiripentol: A Potential Breakthrough for Super-Refractory Status Epilepticus

The research offers a glimmer of hope for patients with SRSE, a condition that often poses significant challenges for clinicians. The findings suggest that STP, a medication previously shown to be effective in other forms of epilepsy, might also be a valuable treatment option for SRSE. This discovery opens avenues for further research into the role of STP in managing this severe form of epilepsy.

Navigating the Desert of Epilepsy

This research is a reminder that even in the most challenging neurological landscapes, hope can emerge. The study suggests that STP, like a resilient camel navigating a vast desert, might be able to provide relief for patients with SRSE. This discovery encourages further exploration into the therapeutic potential of STP, potentially leading to improved outcomes for those battling this debilitating neurological condition.

Dr.Camel's Conclusion

This research is a testament to the ongoing search for solutions in the desert of epilepsy! The promising results with STP for super-refractory status epilepticus highlight the importance of relentless pursuit of new treatments for this challenging neurological condition. It's a reminder that even in the face of seemingly insurmountable obstacles, hope can emerge, offering a brighter future for patients struggling with epilepsy.
Date :
  1. Date Completed 2016-05-26
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25809474

DOI: Digital Object Identifier

10.1111/ane.12403

Related Literature

Article Analysis
・Side Effects of stiripentol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.